Yael Margolin

Insider Reports History

Location
Indianapolis, IN
Signature
/s/ Amir Reichman, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Yael Margolin:

Company Role Class Num Shares Value Price $ Report Date Ownership
POINT Biopharma Global Inc. Director Common Stock 0 $12.45 27 Dec 2023 Direct
POINT Biopharma Global Inc. Director Stock Option (Right to Buy) 0 27 Dec 2023 Direct

Insider Reports Filed by Yael Margolin

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SCNI Scinai Immunotherapeutics Ltd. 18 Mar 2026 0 $0 3 Director 18 Mar 2026, 10:08
/report/000110465923129766-margolin-yael-2023-12-27 POINT Biopharma Global Inc. 27 Dec 2023 4 $0 4 Director 27 Dec 2023, 17:35
/report/000110465923068143-margolin-yael-2023-06-01 POINT Biopharma Global Inc. 01 Jun 2023 1 $0 4 Director 05 Jun 2023, 17:35
SCNI BiondVax Pharmaceuticals Ltd. 01 Jan 2023 0 $0 3/A Director 23 Jan 2023, 07:16
/report/000110465922121618-margolin-yael-2022-11-21 POINT Biopharma Global Inc. 21 Nov 2022 1 +$11,218 4 Director 23 Nov 2022, 11:43
/report/000110465922068508-margolin-yael-2022-06-02 POINT Biopharma Global Inc. 02 Jun 2022 1 $0 4 Director 06 Jun 2022, 16:04
/report/000110465921090265-margolin-yael-2021-07-06 POINT Biopharma Global Inc. 06 Jul 2021 1 $0 4 Director 08 Jul 2021, 16:40
/report/000110465921087819-margolin-yael-2021-06-30 POINT Biopharma Global Inc. 30 Jun 2021 0 $0 3 Director 30 Jun 2021, 21:22